New research suggests that individuals who discontinue popular GLP-1 drugs like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who halt conventional lifestyle programs.
Published data in a leading health publication demonstrates that while obese individuals frequently drop about a fifth of their total mass while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.
"Users using such medications must be aware of the potential of rapid weight regain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
That rate of recovery means a reversion to pre-treatment mass within about a year and a half.
Comparing Approaches
The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with conventional dieting.
The team note that individuals who shed pounds through diet and exercise generally see a more gradual weight regain—perhaps 100 grams monthly—once they finish.
The Reason for the Fast Rebound
Doctors suggest the mechanism of the injections explains the heightened regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication results in hunger is uncontrolled, making excessive eating much more probable."
A Chronic Condition?
Medical guidelines advise the injections for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, given the likelihood of weight regain, the therapy is often long-term.
This view is echoed by drug manufacturers, who say that the results "highlight the chronic nature of excess weight," similar to managing diseases like high blood pressure.
User Testimonies
People who have discontinued the medication explain a intense return of appetite.
"It was like something that goes on and I was suddenly starving," said one woman.
The struggle is exacerbated if users have not established sustainable lifestyle or habit changes during treatment.
Growing Interest
Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is more common among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
Finally, experts stress that while GLP-1 drugs are effective tools for weight loss, they are not a permanent cure and lasting health benefits relies on integrated lifestyle changes.